MannKind Corp (MNKD.OQ)
MNKD.OQ on NASDAQ Stock Exchange Global Market
1.70USD
20 Apr 2018
1.70USD
20 Apr 2018
Change (% chg)
$-0.09 (-5.03%)
$-0.09 (-5.03%)
Prev Close
$1.79
$1.79
Open
$1.79
$1.79
Day's High
$1.79
$1.79
Day's Low
$1.67
$1.67
Volume
436,890
436,890
Avg. Vol
664,702
664,702
52-wk High
$6.96
$6.96
52-wk Low
$0.67
$0.67
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
Name | Age | Since | Current Position |
---|---|---|---|
Kent Kresa |
78 | 2016 | Chairman of the Board |
Michael Castagna |
40 | 2017 | Chief Executive Officer, Director |
Rosabel Alinaya |
56 | 2017 | Acting Chief Financial Officer, Senior Vice President, Chief Accounting Officer |
Steven Binder |
54 | 2017 | Chief Financial Officer, Principal Accounting Officer |
Linda Adreveno |
60 | 2015 | Senior Vice President - Human Resources |
- BRIEF-Mannkind Announces $28.0 Million Registered Direct Offering
- BRIEF-MannKind Restructures $79.7 Mln Debt Obligation To The Mann Group
- BRIEF-Mannkind Corporation Q4 Loss Per Share $0.28
- BRIEF-David Kendall Joins MannKind As Chief Medical Officer
- BRIEF-Mannkind, On Jan 18, Co, Unit Entered Into Exchange, Sixth Amendment To Facility Agreement With Deerfield